Citation Impact
Citing Papers
Directed evolution of the tryptophan synthase β-subunit for stand-alone function recapitulates allosteric activation
2015 StandoutNobel
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
2009
Comprehensive computational design of ordered peptide macrocycles
2017 StandoutScienceNobel
Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity
2005
Actin retrograde flow actively aligns and orients ligand-engaged integrins in focal adhesions
2017 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
A Sulfilimine Bond Identified in Collagen IV
2009 StandoutScienceNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy
2003
Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy
2011
T cell defined tumor antigens
1997
Tumor-targeting peptides from combinatorial libraries
2016
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Inflammation and cancer
2002 StandoutNature
How Tumors Become Angiogenic
1996
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Adenovirus Transduction and Culture Conditions Affect the Immunogenicity of Murine Dendritic Cells
2005
Immunology and immunotherapy approaches for prostate cancer
2007
The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors
2006
The Human T Cell Response to Melanoma Antigens
2006
DC-SIGN
2000 StandoutNobel
Human tumor antigens recognized by T-cells
1997
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Type I interferon response and innate immune sensing of cancer
2012
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Cancer vaccines based on the identification of genes encoding cancer regression antigens
1997
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Origin, maturation and antigen presenting function of dendritic cells
1997
Cancer driver mutations in protein kinase genes
2008
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Human tumor antigens for cancer vaccine development
1999
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Cancer vaccines: between the idea and the reality
2003
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
TAP off - tumors on
1997
Generation and functional characterization of mouse monocyte-derived dendritic cells
1999
The opposing roles of laminin-binding integrins in cancer
2016
Mammalian collagen IV
2008
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
1997
Cancer-related inflammation
2008 StandoutNature
Gene Signature in Melanoma Associated With Clinical Activity
2010
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles
2006
T-cell responses of vaccinated cancer patients
2003
A cell line model for the differentiation of human dendritic cells
2005
Tumors and inflammatory infiltrates: Friends or foes?
2002
Accurate design of megadalton-scale two-component icosahedral protein complexes
2016 StandoutScienceNobel
Dendritic Cell Vaccines for Cancer Immunotherapy
1999
The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function
1996
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
1994
Characterization of Murine Dendritic Cells Derived from Adherent Blood Mononuclear Cells In Vitro
2000
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
1998 StandoutScienceNobel
Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70
2000 StandoutNobel
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
1994
Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.
1996
Innate immune sensing of cancer: clues from an identified role for type I IFNs
2012
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.
2001 StandoutNobel
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
flt3 Ligand in Cooperation With Transforming Growth Factor-β1 Potentiates In Vitro Development of Langerhans-Type Dendritic Cells and Allows Single-Cell Dendritic Cell Cluster Formation Under Serum-Free Conditions
1997
Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.
2002
Identification of the Genes Encoding Cancer Antigens: Implications for Cancer Immunotherapy
1996
Homeostatic Proliferation as an Isolated Variable Reverses CD8+ T Cell Anergy and Promotes Tumor Rejection
2006
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance
2004
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
flt3 Ligand in Cooperation With Transforming Growth Factor-β1 Potentiates In Vitro Development of Langerhans-Type Dendritic Cells and Allows Single-Cell Dendritic Cell Cluster Formation Under Serum-Free Conditions
1997
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Immunosuppressive Strategies that are Mediated by Tumor Cells
2006
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
1997 StandoutNobel
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
1994
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Immunobiology of Dendritic Cells
2000 Standout
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
2011
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
1997
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
1998
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
1999
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
1994
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
New Generation Vaccine Induces Effective Melanoma-Specific CD8+ T Cells in the Circulation but Not in the Tumor Site
2006
Combinatorial Peptide Libraries: Mining for Cell-Binding Peptides
2013
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells
2013 Standout
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
1996
Palaeoproteomic evidence identifies archaic hominins associated with the Châtelperronian at the Grotte du Renne
2016 StandoutNobel
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Human tumor antigens recognized by T lymphocytes.
1996
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of Roberta Mortarini being referenced
Tumor-Reactive CD8+ Early Effector T Cells Identified at Tumor Site in Primary and Metastatic Melanoma
2010
Constitutive Expression and Costimulatory Function of LIGHT/TNFSF14 on Human Melanoma Cells and Melanoma-Derived Microvesicles
2005
Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma
2006
The α3β1 Integrin Is Involved in Melanoma Cell Migration and Invasion
1995
Multiple sub‐sets of Cd4+ and Cd8+ cytotoxic T‐cell clones directed to autologous human melanoma identified by cytokine profiles
1994
Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction
2002
Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?
2002
Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression.
1991
Targeting Heat Shock Proteins on Cancer Cells: Selection, Characterization, and Cell-Penetrating Properties of a Peptidic GRP78 Ligand
2006
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
2008
Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
1994
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
2003
Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
1995
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors.
1999
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
1993
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
1993
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.
1997
Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.
2000
Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.
1996
An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions
1999
Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.
1996
The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp-9) activity
2000
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
1995
Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases.
1995